FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to novel compounds of formula (I), as well as to pharmaceutical compositions based thereon and use.
(I).
EFFECT: obtaining novel compounds which can be used as medicinal agents for treating diseases and infections caused by Acinetobacter baumannii.
22 cl, 5 tbl, 255 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | 2019 |
|
RU2795374C2 |
COMPOUNDS AND METHODS FOR ENHANCED DEGRADATION OF TARGET PROTEINS AND OTHER POLYPEPTIDES BY AN E3 UBIQUITIN LIGASE | 2013 |
|
RU2666530C2 |
COMPOUNDS AND METHODS FOR ENHANCING DEGRADATION OF TARGET PROTEINS AND OTHER POLYPEPTIDES, USING E3 UBIQUITIN LIGASE | 2013 |
|
RU2781452C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
REGULATORS OF DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND USE | 2019 |
|
RU2803499C1 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
ANTI-ENDOPARASITIC DEPSIPEPTIDES | 2018 |
|
RU2747149C1 |
3-AMINOALKYL-1,4-DIAZEPAN-2-ONE MELANOCORTIN-5 RECEPTOR ANTAGONISTS | 2009 |
|
RU2530017C2 |
SULFONAMIDE-CONTAINING BINDING SYSTEMS FOR MEDICINAL CONJUGATES | 2014 |
|
RU2729194C2 |
SUBSTITUTED DERIVATIVES OF N-BENZYLINDOL-3-YL-GLYOXYLIC ACID POSSESSING ANTITUMOR EFFECT (VARIANTS), THEIR ACID-ADDITIVE SALTS (VARIANTS), PHARMACEUTICAL PREPARATION, PHARMACEUTICAL FORMULATION | 2000 |
|
RU2266280C2 |
Authors
Dates
2020-08-11—Published
2016-10-24—Filed